The US Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the latest computer-assisted detection (CADe) radiography solution from global AI company Qure.ai. It ...

University Hospitals Cleveland Medical Center is now the flagship location for a clinical trial of a new AI-informed lung cancer screening technology. On Wednesday morning, April 2, UH announced its ...

Fractal Analytics anticipates increased AI use by companies to enhance efficiency and cut costs, despite Middle East tensions affecting global economic growth. The firm posted a solid Q3 2025 profit ...

This morning healthcare AI company Qure.ai announced the launch of its new AI technology which can identify bleeds, fractures, and other critical abnormalities in the head CT scans. “Qure.ai’s new ...

Every year, approximately 2 billion chest X-rays are performed around the world. They are affordable, quick, and often used in frontline healthcare to efficiently survey for abnormalities such as ...

Indian medical imaging AI company Qure.ai has developed a new AI-powered co-pilot for optimising resources in resource-constrained primary care settings. Called AIRA, this tool for community health ...

Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) tools to make healthcare more accessible and affordable to patients around the world in medical imaging & care ...

NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Medical imaging AI innovator, Qure.ai, has received breakthrough device designation from the Food and Drug Administration's (FDA) Center for Devices and ...

Qure.ai has partnered with Microsoft to onboard its end-to-end lung cancer detection, measurement and management suite onto Microsoft’s Precision Imaging Network. The move is positioned to streamline ...

In an effort to advance health equity and reach the people that need help most, global digital health innovator Qure.ai has received a grant from the Gates Foundation.